1132
S. Jarosz et al. / Tetrahedron: Asymmetry 19 (2008) 1127–1133
4.9. Reaction of epoxide 16 with water
(C-5), 31.40 (C-4). NOESY (diagnostic): H-1/H-2, H-1/
H-5, H-1/H-9, H-6/H-7, H-6/H-8.
Reaction of epoxide 16 (40 mg, 0.07 mmol) under the same
conditions as described in Section 4.8. afforded diol 19 in
65% yield.
4.10.4. (1S,2R,3R,5R,6R,7R,8R,9R)-2,3-Di-hydroxy-7,8,9-
tri-O-benzyl-5-benzyloxymethyl-bicyclo[4.3.0]nonane
20.
[a]D = +33.8 (c 1, CHCl3); HRMS m/z: 617.28769
1
[C38H42O6Na (M+Na+) requires 617.28736]. H NMR: d
4.10. Characteristics of the products of the ring opening
reactions of epoxides 15 and 16
4.44–4.76 (8H, 4 ꢀ OCH2Ph), 4.12 (dd, J8,9 3.0, J1,9 7.5,
H-9), 3.99 (ꢁt, H-7), 3.91 (ꢁt, H-8), 3.60 (ꢁt, H-2), 3.54
(ddd, J3,4eq 4.4, J2,3 8.7, J3,4ax 12.6, H-3), 3.29 (dd, J 4.4,
Jgem 9.1, one of CH2OBn), 3.19 (dd, J 5.9, one of
CH2OBn), 2.24 (ddd, J1,2 10.4, J1,6 13.2, H-1), 2.10 (ddd,
J3,4eq = J4eq,5 4.3, Jgem 12.7, Heq-4), 2.02 (m, H-5), 1.63
(ddd, J6,7 3.2, J5,6 10.9, H-6), 1.30 (m, Hax-4); 13C NMR:
d 90.17 (C-8), 81.91 (C-9), 70.01 (C-7), 74.78 and 74.72
(C-2 and C-3), 73.57, 73.10, 72.25, 71.50 (4 ꢀ OCH2Ph),
72.47 (CH2OBn), 47.59 (C-1), 45.45 (C-6), 35.91 (C-4),
34.56 (C-5).
4.10.1. (1S,2S,3S,5R,6R,7R,8R,9R)-2-Azido-2-deoxy-3-hydr-
oxy-7,8,9-tri-O-benzyl-5-benzyloxymethyl-bicyclo[4.3.0]non-
ane 17. [a]D = +6.5 (c 1, CHCl3); HRMS m/z: 642.29110
[C38H41N3O5Na (M+Na+) requires 642.29384].
This compound was characterized further as the acetate:
1H NMR: d 4.98 (dd, J2,3 3.0, J3,4 6.3, H-3), 4.35–4.75
(8H, 4 ꢀ OCH2Ph), 4.18 (dd, J8,9 5.2, J1,9 9.3, H-9), 3.98
(ꢁt, H-7), 3.88 (dd, J7,8 3.6, H-8), 3.84 (ꢁt, H-2), 3.25
(dd, J 4.3, Jgem 9.1, one of CH2OBn), 3.14 (dd, J 6.1, one
of CH2OBn), 2.60 (ddd, J1,2 2.3, J1,6 13.1, H-1), 2.10 (m,
H-5), 2.04 (3H, s, CH3CO), 1.92 (ddd, J6,7 3.0, J5,6 8.8,
H-6), 1.81 (m, one of H-4), 1.63 (ddd, J4,5 12.6, Jgem
15.0, one of H-4); 13C NMR: d 169.97 (CH3CO), 91.04
(C-8), 82.51 (C-9), 76.52 (C-7), 73.41, 73.16, 72.53, 72.37
(4 ꢀ OCH2Ph and CH2OBn), 71.39 (C-3), 60.34 (C-2),
40.84 (C-1), 40.34 (C-6), 32.87 (C-5), 28.85 (C-4), 21.33
(CH3CO); IR m cmꢂ1 (film): 2114 (strong, –N@N@N).
NOESY (diagnostic): H-1/H-2, H-1/H-5, H-1/H-9, H-6/
H-7, H-6/H-8.
NOESY (diagnostic): H-1/H-3, H-1/H-9, H-2/Hax-4, H-2/
H-6, H-3/Heq-4, H-3/H-5, H-6/Hax-4, H-6/H-7, H-6/H-8.
4.10.5. (1S,2S,3S,5R,6R,7R,8R,9R)-3-Azido-3-deoxy-2-hydr-
oxy-7,8,9-tri-O-benzyl-5-benzyloxymethyl-bicyclo[4,3,0]-
nonane 21. [a]D = ꢂ7.4 (c 1, CHCl3); HRMS m/z:
642.29403 [C38H41N3O5Na (M+Na+) requires 642.29384].
1H NMR: d 4.28–4.67 (8H, 4 ꢀ OCH2Ph), 4.17 (dd, J8,9
3.6, J1,9 8.2, H-9), 4.06 (m, H-2), 3.96 (ꢁt, H-7), 3.78 (ꢁt,
H-8), 3.73 (m, H-3), 3.22 (dd, J 4.4, Jgem 9.2, one of
CH2OBn), 3.14 (dd, J 5.7, one of CH2OBn), 2.46 (ddd,
J1,2 1.4, J1,6 13.6, H-1), 2.07 (m, H-5), 1.95 (m, H-6), 1.73
(2H, m, both H-4); 13C NMR: d 90.25 (C-8), 85.60 (C-9),
76.66 (C-7), 73.55, 73.02, 72.27, 72.07 (4 ꢀ OCH2Ph),
72.67 (CH2OBn), 68.54 (C-2), 61.09 (C-3), 41.40 (C-1),
39.74 (C-6), 32.26 (C-5), 28.00(C-4). NOESY (diagnostic):
H-1/H-2, H-1/H-5, H-1/H-9, H-6/H-7, H-6/H-8.
4.10.2.
(1S,2R,3R,5R,6R,7R,8R,9R)-3-Azido-3-deoxy-2-
hydroxy-7,8,9-tri-O-benzyl-5-benzyloxymethyl-bicyclo[4.3.0]-
nonane 18. [a]D = +23.7 (c 1, CHCl3); HRMS m/z:
642.291460
[C38H41N3O5Na
(M+Na+)
requires
642.29384]. 1H NMR: d 4.33–4.78 (8H, 4 ꢀ OCH2Ph),
4.12 (dd, J8,9 2.8, J1,9 7.2, H-9), 3.95 (ꢁt, H-7), 3.90 (ꢁt,
H-8), 3.66 (ꢁt, H-2), 3.32 (ddd, J3,4eq 4.7, J2,3 9.3, J3,4ax
13.9, H-3), 3.28 (dd, J 4.0, Jgem 9.1, one of CH2OBn),
3.15 (dd, J 6.1, one of CH2OBn), 2.25 (ddd, J1,2 10.6, J1,6
17.9 H-1), 2.14 (m, one of H-4), 2.01 (m, H-5), 1.60 (m,
H-6), 1.32 (m, one of H-4); 13C NMR: d 89.87 (C-8),
81.77 (C-9), 76.87 (C-7), 73.65, 73.15, 72.29, 71.92, and
71.68 (4 ꢀ OCH2Ph and CH2OBn), 73.03 (C-2), 65.91 (C-
3), 48.36 (C-1), 44.72 (C-6), 34.93 (C-5), 33.67 (C-4); IR m
cmꢂ1 (film): 2100 (strong, –N@N@N). NOESY (diagnos-
tic): H-1/H-3, H-1/H-5, H-1/H-9, H-2/H-6, H-3/H-5, H-
6/H-7.
Acknowledgment
This work was financed by the Grant No. PBZ-KBN-126/
T09/07 from the Ministry of Science and Higher
Education.
References
1. Selected recent reviews and papers: Arjona, A.; Gomez, A.
M.; Lopez, J. C.; Plumet, J. Chem. Rev. 2007, 107, 1919;
Long, M.; Ziegler, Th. Eur. J. Org. Chem. 2007, 768; Zhou,
J.; Wang, G.; Zhang, L.-H.; Ye, X.-S. Curr. Org. Chem. 2006,
10, 625; Podeschwa, M. A. L.; Plettenburg, O.; Altenbach,
H.-J. Eur. J. Org. Chem. 2005, 3101, and 3116; Freeman, S.;
Hudlicky, T. Bioorg. Med. Chem. Lett. 2004, 14, 1209, and
references cited therein.
4.10.3. (1S,2S,3S,5R,6R,7R,8R,9R)-2,3-Di-hydroxy-7,8,9-
tri-O-benzyl-5-benzyloxymethyl-bicyclo[4.3.0]nonane
19.
[a]D = ꢂ1.3 (c 1, CHCl3); HRMS m/z: 617.28444
1
[C38H42O6Na (M+Na+) requires 617.28736]. H NMR: d
4.38–4.75 (8H, 4 ꢀ OCH2Ph), 4.26 (dd, J8,9 3.8, J1,9 8.3,
H-9), 4.12 (ꢁt, H-2), 4.05 (ꢁt, H-7), 3.92 (dd, J1,2 2.9,
J3,4 6.0, H-3), 3.86 (ꢁt, H-8), 3.32 (dd, J 4.7, Jgem 9.1,
one of CH2OBn), 3.24 (dd, J 6.0, one of CH2OBn), 2.65
(ddd, J1,2 2.0, J1,6 13.7, H-1), 2.25 (m, H-5), 2.00 (ddd,
J6,7 3.0, J5,6 10.9, H-6), 1.71–1.74 (2H, m, both H-4); 13C
NMR: d 90.52 (C-8), 85.80 (C-9), 76.91 (C-7), 73.47,
73.30, 73.04, 72.19, 72.01 (4 ꢀ OCH2Ph and CH2OBn),
70.39 (C-2), 69.59 (C-3), 41.14 (C-1), 40.13 (C-6), 31.63
2. Ferrier, R. J.; Middleton, S. Chem. Rev. 1993, 93, 2779.
3. Sollogub, M.; Millet, J.-M.; Sinay, P. Angew. Chem., Int. Ed.
¨
2000, 39, 362.
4. Jorgensen, M.; Hadwiger, P.; Madsen, R.; Stutz, A. E.;
¨
Wrodnigg, T. M. Curr. Org. Chem. 2000, 4, 565; microreview:
Madsen, R. Eur. J. Org. Chem. 2007, 399.
5. Roush, W. R.; Koyama, K.; Curtin, M. L.; Moriarty, K. J. J.
Am. Chem. Soc. 1996, 118, 7502.